# Radiofrequency Ablation in Breast Cancer

> **NCT02281812** · NA · TERMINATED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 40 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Radiofrequency ablation

## Key facts

- **NCT ID:** NCT02281812
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Increased local adverse effect (breast inflamation and infection)
- **Last updated:** 2018-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02281812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02281812, "Radiofrequency Ablation in Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02281812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*